AI Article Synopsis

  • The tissue culture smallpox vaccine has key advantages over the traditional dermal vaccine, including being free from bacterial contamination and serum proteins.
  • It is produced using Japanese quail embryo cultures that are monitored for viral contaminants, making it safer for use.
  • Clinical trials with 800 volunteers showed no adverse reactions, and the tissue culture vaccine demonstrated superior antibody response compared to the dermal vaccine.

Article Abstract

The tissue culture vaccine against smallpox has some important advantages over the dermal preparation: it is free from bacterial contamination, contains no serum proteins, and suitable for intradermal inoculation with jet injections. The virus for the tissue culture smallpox vaccine is grown in Japanese quail embryo cultures controlled for the absence of contaminating viruses. In trials of the tissue culture smallpox vaccine in 800 revaccinated volunteers no untoward reactions or complications were observed. The antigenic activity of the tissue culture smallpox vaccine was superior to that of dermal vaccine used in the same dose: the geometric mean neutralizing antibody titre after vaccination with the tissue and dermal preparations was 1 : 256 and 1 : 158, respectively, and the antibody rise was 4.5- and 2.5-fold.

Download full-text PDF

Source

Publication Analysis

Top Keywords

smallpox vaccine
16
tissue culture
16
culture smallpox
12
tissue
6
vaccine
6
smallpox
5
[study properties
4
properties tissue
4
tissue smallpox
4
vaccine manufactured
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!